Biomimetic Nanoparticles for Targeted and Efficient Cancer Therapy: Progress, Challenges and Perspectives
Open Access
- 1 February 2026
- journal article
- review article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-40
Abstract
Cancer remains a prominent cause of global mortality, with over 200 identified forms, and is projected to have a 25% increase in fatalities by 2030. Early diagnosis and treatment are crucial, but current therapy, which includes surgery, chemotherapy, immunotherapy, hormonal therapy, targeted therapy, and radiotherapy, faces challenges such as non-targeted drug distribution, toxicity, and limited efficacy. In recent years, biomimetic nanoparticles have emerged as a promising nanocarrier with great potential that enables site-specific drug release, improves biocompatibility, prolongs circulation time, and minimizes immune responses. Among various biomimetic nanoparticles, nanoparticles coated with cell membranes, such as those from cancer cells, immune cells, and stem cells, have been shown to have great potential for cancer treatment. The cell membrane-coated nanoparticles, further functionalized with tumor-specific ligands, demonstrated potential in improving half-life, drug specificity, and overall therapeutic efficacy. In this comprehensive article, we have reviewed recent advances in cell membrane-coated biomimetic nanoparticle systems for cancer therapy. We discussed the biomimetic nanoparticles coated with membranes of red blood cells, cancer cells, platelet cells, macrophages, exosomes, hybrid cells, and protein/serum albumin for cancer therapy. This review also highlights challenges associated with large-scale production, maintaining structural integrity during drug loading, clinical and biosafety aspects, regulatory requirements, and the clinical translation of the cell membrane-coated biomimetic nanoparticle systems.Keywords
This publication has 168 references indexed in Scilit:
- Biomimetic and bioinspired nano‐platforms for cancer vaccine developmentExploration, 2023
- RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapyJournal of Materials Science: Materials in Medicine, 2023
- Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical ApplicationsSmall Methods, 2022
- Bioactive Materials Promote Wound Healing through Modulation of Cell BehaviorsAdvanced Science, 2022
- Mito‐Bomb: Targeting Mitochondria for Cancer TherapyAdvanced Materials, 2021
- Biomimetic Diselenide‐Bridged Mesoporous Organosilica Nanoparticles as an X‐ray‐Responsive Biodegradable Carrier for Chemo‐ImmunotherapyAdvanced Materials, 2020
- Engineering Macrophages for Cancer Immunotherapy and Drug DeliveryAdvanced Materials, 2020
- RBC Membrane Camouflaged Semiconducting Polymer Nanoparticles for Near-Infrared Photoacoustic Imaging and Photothermal TherapyNano-Micro Letters, 2020
- Cell Membrane Coating Technology: A Promising Strategy for Biomedical ApplicationsNano-Micro Letters, 2019
- Nanoparticles in the clinic: An updateBioengineering & Translational Medicine, 2019